What is Lm Technology?

Description: Robert Petit, MD, Chief Scientific Officer of Advaxis, Inc. gives an overview of Advaxis' Lm Technology™, which alters Listeria monocytogenes (Lm) bacteria to stimulate cancer-fighting T-cells directed against cancer antigens. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Shared By : AnnualMeeting2017
Posted on : 06/14/17
Added : 2 years ago
Category : Other